DISEASE INDICATIONS: Macular Degeneration
MANUFACTURER: Roche Registration Limited
USAGE: Intravitreal
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Vabysmo (faricimab-svoa) is a prescription medication prescribed for the treatment of two primary causes of vision impairment: neovascular or "wet" age-related macular degeneration (nAMD) and diabetic macular edema (DME).
